Narrative review / 2020
Morning alternate-day oral iron dosing maximizes fractional absorption compared to daily or divided doses in iron-deficient women.
This review evaluates optimal dosing regimens for oral iron supplementation in iron-deficient women and women with iron deficiency anemia (IDA). Recent studies demonstrated that oral iron doses of at least 60 mg in iron-deficient women and at least 100 mg in women with IDA stimulate an acute increase in hepcidin that persists for 24 hours but subsides by 48 hours. A morning iron dose augments the circadian increase in plasma hepcidin, meaning afternoon or evening doses following a morning dose face increased absorption inhibition. A pooled analysis prepared for the review found that total iron absorption is higher when twice the target daily iron dose is provided on alternate days, suggesting morning doses of 60-120 mg of ferrous salt with ascorbic acid on alternate days may optimize absorption.
- Study type
- Narrative review with pooled analysis
- Who was studied
- Iron-deficient women and women with iron deficiency anemia (IDA)
- What was measured
- Iron absorption, serum hepcidin profiles, and gastrointestinal side effects
THE PAPER
Oral iron supplementation in iron-deficient women: How much and how often?
Stoffel NU, von Siebenthal HK, Moretti D, Zimmermann MB. Mol Aspects Med, 2020.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.